© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

GlobalCapital Bond Awards 2026: Voting now open

Have the chance to put forward your opinion and shape this year’s Bond Awards winners.
I don’t need to work, but I’m tempted to go back
SSA

Eurofima, BNG and NZ agency bring life back to SSA market

BNG deal 'most exciting' while Eurofima will test long-dated demand

UPDATE: ABN Amro returns to euro market with 'defensive' EuGB senior note

◆ Defensive structure for nervous market ◆ Largest book on a busy day for FIG issuance ◆ ABN keeps position of leading bank EuGB issuer
I don’t need to work, but I’m tempted to go back
Sub-sections
  • ABS
    Bankers Healthcare Group (BHG) is returning with its second securitization backed by loans made to high-earning medical professionals. The healthcare consumer lender is expected to see its newest deal well subscribed, considering its popularity last year and its relatively high yield ranging from 2% to 5%.
  • Synlab, the German laboratory diagnostic services company, has set the terms for its €1bn plus IPO on the Frankfurt Stock Exchange.
  • India’s Glenmark Life Sciences, a pharmaceutical ingredients maker, has filed draft paperwork for an IPO of new and existing shares.